| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9008466a40998f8be8e54cd3aceb10a2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2011-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_046459e079ff728cccdf92e60c2ff6c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42cd7fa4cc4f68c9afc8856f7ea7b955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e177346d24ec23bfce5528ede17c03f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c0a9ba8a9f2986e7e04b6bc4928fb3a |
| publicationDate |
2019-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112013007022-B1 |
| titleOfInvention |
USE OF MAGNESIUM STATE |
| abstract |
Use of Magnesium Stearate The invention relates to the use of magnesium stearate in powdered inhalation formulation comprising carrier particles to inhibit or reduce the chemical degradation of an active ingredient containing a group susceptible to hydrolysis. furthermore there is provided an inhalation dry powder pharmaceutical formulation comprising (a) a carrier, (b) magnesium stearate and (a) an active ingredient of hydrolysis susceptible ingredient. |
| priorityDate |
2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |